These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Biological and psychological aspects of a case of Gilles de la Tourette's syndrome. Yeragani VK; Blackman M; Baker GB J Clin Psychiatry; 1983 Jan; 44(1):27-9. PubMed ID: 6571833 [TBL] [Abstract][Full Text] [Related]
8. [Early diagnosis of the Tourette syndrome]. Mel'nichuk PV; Khokhlov AP; Khaĭlova IM Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(10):1450-3. PubMed ID: 6933789 [TBL] [Abstract][Full Text] [Related]
9. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. Sabelli HC; Fawcett J; Gusovsky F; Javaid JI; Wynn P; Edwards J; Jeffriess H; Kravitz H J Clin Psychiatry; 1986 Feb; 47(2):66-70. PubMed ID: 3944066 [TBL] [Abstract][Full Text] [Related]
10. Effect of dietary phenylalanine on the plasma concentrations of phenylalanine, phenylethylamine and phenylacetic acid in healthy volunteers. Davis BA; O'Reilly RL; Placatka CL; Paterson IA; Yu PH; Durden DA Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):611-23. PubMed ID: 1956990 [TBL] [Abstract][Full Text] [Related]
11. Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man. Karoum F; Potkin S; Chuang LW; Murphy DL; Liebowitz MR; Wyatt RJ Biol Psychiatry; 1984 Feb; 19(2):165-78. PubMed ID: 6713036 [TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of metabolites of norepinephrine in Tourette's syndrome. Baker GB; Bornstein RA; Douglass AB; Carroll A; King G Mol Chem Neuropathol; 1990 Dec; 13(3):225-32. PubMed ID: 2099785 [TBL] [Abstract][Full Text] [Related]
13. Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls. Potkin SG; Wyatt RJ; Karoum F Psychopharmacol Bull; 1980 Jan; 16(1):52-4. PubMed ID: 7360842 [No Abstract] [Full Text] [Related]
14. Tourette's syndrome in patients referred for allergy evaluation. Kim H; Moote W; Mazza J Ann Allergy Asthma Immunol; 1997 Oct; 79(4):347-9. PubMed ID: 9357381 [TBL] [Abstract][Full Text] [Related]
15. [Biological study of 2 cases of Gilles de la Tourette's disease]. Yvonneau M Rev Neurol (Paris); 1972 Jan; 126(1):65-70. PubMed ID: 4508361 [No Abstract] [Full Text] [Related]
16. Costs of control: decreased motor cortex engagement during a Go/NoGo task in Tourette's syndrome. Thomalla G; Jonas M; Bäumer T; Siebner HR; Biermann-Ruben K; Ganos C; Orth M; Hummel FC; Gerloff C; Müller-Vahl K; Schnitzler A; Münchau A Brain; 2014 Jan; 137(Pt 1):122-36. PubMed ID: 24176975 [TBL] [Abstract][Full Text] [Related]
17. Brain magnetic resonance spectroscopy in Tourette's disorder. DeVito TJ; Drost DJ; Pavlosky W; Neufeld RW; Rajakumar N; McKinlay BD; Williamson PC; Nicolson R J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1301-8. PubMed ID: 16292123 [TBL] [Abstract][Full Text] [Related]
18. Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults. Yeh CB; Lee CH; Chou YH; Chang CJ; Ma KH; Huang WS Nucl Med Commun; 2006 Oct; 27(10):779-84. PubMed ID: 16969259 [TBL] [Abstract][Full Text] [Related]
19. [Control of inner speech and Gilles de la Tourette's syndrome]. Vercueil L Encephale; 2003; 29(5):460-2. PubMed ID: 14615696 [TBL] [Abstract][Full Text] [Related]
20. [Concentration of serum and 24-hour urine free amino acids in children with the la Tourette syndrome]. Malyshev IuI Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(10):1466-8. PubMed ID: 6594862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]